FDA Drug Application (011287) for KAYEXALATE by CONCORDIA PHARMS INC

Back to FDA Applications sponsored by CONCORDIA PHARMS INC

Application Number011287
Product Number001
FormPOWDER;ORAL, RECTAL
Dosage453.6GM/BOT
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameKAYEXALATE
Active IngredientSODIUM POLYSTYRENE SULFONATE

Active IngredientCount
List of drugs with Active Ingredient SODIUM POLYSTYRENE SULFONATE5


Back to FDA Applications sponsored by CONCORDIA PHARMS INC